Androgen-dependent carcinoma of the prostate or of the male mammary gland.
Hypercalcemia accompanying malignant tumors.
Past or present liver tumors.
Hypersensitivity to the active substance or to any of the excipients.
The use of Testosterone undecanoate (Nebido) in women is contraindicated.